Taiho Hooks Up with MD Anderson on Refractory Cancers

September 25, 2020
Taiho Pharmaceutical said on September 24 that it has formed a strategic collaboration with the University of Texas MD Anderson Cancer Center to speed up the development of novel therapies for patients with difficult-to-treat cancers, such as those with brain...read more